Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopeniaNovel treatment targets BTK through multi-immune ...

Sanofi’s Wayrilz, the first BTK inhibitor to treat immune thrombocytopenia gets European approval: Paris Saturday, December 27, 2025, 12:00 Hrs [IST] Sanofi, an R&D driven, AI-p ...

Sanofi's Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.

TODAY, the world marks World Sickle Cell Day, a moment to draw attention to one of the country’s most pressing yet often overlooked health challenges—sickle cell disease (SCD). It is a condition ...

Agios upgraded after FDA approval of Aqvesme for thalassemia. Explore AGIO’s financial outlook, upside potential, and future ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

The City of Lidgerwood has received a $10,000 donation from the KC Group to help purchase a permanent generator for the ...

The weekend after Christmas is often one of the busiest for U.S. ski resorts, but the chairs aren’t spinning at Telluride ...

We earn a commission for products purchased through some links in this article. ©2025 Hearst UK is the trading name of the National Magazine Company Ltd, 30 Panton ...